A Review of the Use of Inhaled Nitric Oxide in the PICU at Red Cross War Memorial Children's Hospital, 2011-2015: A Retrospective Cohort Study

Overview

Journal South Afr J Crit Care

Specialty Critical Care

Date 2022 May 2

PMID 35493980

Authors

S Padayachee

S Salie

Affiliations

Soon will be listed here.

Abstract

Background: Inhaled nitric oxide (iNO) functions as a selective pulmonary vasodilator. It is an expensive treatment that is often employed as rescue therapy for refractory hypoxaemia in acute respiratory distress syndrome (ARDS) and pulmonary hypertension (PHT) following cardiac surgery.

Objectives: To describe the use of iNO and the cost of treatment in our paediatric intensive care unit (PICU).

Methods: A retrospective descriptive study of all patients treated with iNO in the PICU at Red Cross War Memorial Children's Hospital (RCWMCH) from 2011 - 2015.

Results: We treated 140 patients with iNO, 82 for PHT following cardiac surgery, 53 for ARDS and 5 for persistent pulmonary hypertension of the newborn (PPHN). A response to treatment was observed in 64% of the cohort as a whole, 80% of those with PPHN, 67% of those with PHT post-cardiac surgery, and 64% of those with ARDS. A longer duration of PICU and hospital admission, and higher in-hospital mortality (53%), was seen in the group with ARDS, in particular those with adenoviral infection (63%), when compared with patients treated for PHT post-cardiac surgery (18%) and for PPHN (20%). The total cost of treatment with iNO was ZAR1 441 376 for the 5-year period studied. There are no protocols guiding the use of iNO in our unit, and it was found that response to treatment was not being objectively measured and documented, and that practice varied between clinicians.

Conclusion: Considering the cost of treatment and lack of evidence showing improved outcomes with iNO therapy, its continued use in our resource-limited setting should be guided by protocol.

Contributions Of The Study: There is a paucity of data regarding the indications for use, and outcomes of patients treated with iNO in resource-limited settings. We did not find evidence of improved outcomes in patients treated with iNO despite the high costs of the therapy. Protocols should be developed to guide the use of iNO in resource-limited settings.

References

Day R, Hawkins J, McGOUGH E, Crezee K, Orsmond G . Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg. 2000; 69(6):1907-12; discussion 1913. DOI: 10.1016/s0003-4975(00)01312-6. View

Medjo B, Atanaskovic-Markovic M, Nikolic D, cuturilo G, Djukic S . Inhaled nitric oxide therapy for acute respiratory distress syndrome in children. Indian Pediatr. 2012; 49(7):573-6. DOI: 10.1007/s13312-012-0119-0. View

Hansmann G, Apitz C . Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016; 102 Suppl 2:ii67-85. DOI: 10.1136/heartjnl-2015-309103. View

Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C . Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999; 25(9):911-9. DOI: 10.1007/s001340050982. View

Adhikari N, Dellinger R, Lundin S, Payen D, Vallet B, Gerlach H . Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med. 2013; 42(2):404-12. DOI: 10.1097/CCM.0b013e3182a27909. View

Dowell J, Thomas N, Yehya N . Association of Response to Inhaled Nitric Oxide and Duration of Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome. Pediatr Crit Care Med. 2017; 18(11):1019-1026. PMC: 5679068. DOI: 10.1097/PCC.0000000000001305. View

Kinsella J, Abman S . Inhaled nitric oxide therapy in children. Paediatr Respir Rev. 2005; 6(3):190-8. DOI: 10.1016/j.prrv.2005.06.002. View

Gupta P, Richardson T, Hall M, Bertoch D, Hebbar K, Fortenberry J . Effect of Inhaled Nitric Oxide on Outcomes in Children With Acute Lung Injury: Propensity Matched Analysis From a Linked Database. Crit Care Med. 2016; 44(10):1901-9. DOI: 10.1097/CCM.0000000000001837. View

Gebistorf F, Karam O, Wetterslev J, Afshari A . Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016; (6):CD002787. PMC: 6464789. DOI: 10.1002/14651858.CD002787.pub3. View

10.

Bizzarro M, Gross I, Barbosa F . Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev. 2014; (7):CD005055. PMC: 10728583. DOI: 10.1002/14651858.CD005055.pub3. View

11.

Steinhorn R . Therapeutic approaches using nitric oxide in infants and children. Free Radic Biol Med. 2011; 51(5):1027-34. PMC: 3156336. DOI: 10.1016/j.freeradbiomed.2011.01.006. View

12.

Morris K, Beghetti M, Petros A, Adatia I, Bohn D . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med. 2000; 28(8):2974-8. DOI: 10.1097/00003246-200008000-00048. View

13.

Fioretto J, de Moraes M, Bonatto R, Ricchetti S, Carpi M . Acute and sustained effects of early administration of inhaled nitric oxide to children with acute respiratory distress syndrome. Pediatr Crit Care Med. 2004; 5(5):469-74. DOI: 10.1097/01.pcc.0000137986.83738.d7. View

14.

Adhikari N, Burns K, Friedrich J, Granton J, Cook D, Meade M . Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007; 334(7597):779. PMC: 1852043. DOI: 10.1136/bmj.39139.716794.55. View

15.

Afshari A, Brok J, Moller A, Wetterslev J . Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg. 2011; 112(6):1411-21. DOI: 10.1213/ANE.0b013e31820bd185. View

16.

Bronicki R, Fortenberry J, Schreiber M, Checchia P, Anas N . Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome. J Pediatr. 2014; 166(2):365-9.e1. DOI: 10.1016/j.jpeds.2014.10.011. View

17.

Kaestner M, Schranz D, Warnecke G, Apitz C, Hansmann G, Miera O . Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016; 102 Suppl 2:ii57-66. DOI: 10.1136/heartjnl-2015-307774. View

18.

Day R, Allen E, Witte M . A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest. 1997; 112(5):1324-31. DOI: 10.1378/chest.112.5.1324. View

19.

Miller O, Tang S, Keech A, Pigott N, Beller E, Celermajer D . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet. 2000; 356(9240):1464-9. DOI: 10.1016/S0140-6736(00)02869-5. View

20.

Dobyns E, Cornfield D, Anas N, Fortenberry J, Tasker R, Lynch A . Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999; 134(4):406-12. DOI: 10.1016/s0022-3476(99)70196-4. View